← Browse by Condition
Medical Condition

locally advanced or metastatic conventional chondrosarcoma with an idh1 mutation untreated or previously treated with 1 systemic treatment regimen

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06127407 Phase 3
Recruiting

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

Enrollment
136 pts
Location
United States, Austr...
Sponsor
Servier Bio-Innovation LLC
View Trial →